Analysts Point To CRISPR Therapeutics AG (NASDAQ: CRSP) Growth In The Future

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

As a NASDAQ listed company, CRSP falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of CRISPR Therapeutics AG is $4.71B. A total of 1.38 million shares were traded on the day, compared to an average of 1.71M shares.

In the most recent transaction, Kulkarni Samarth sold 19,582 shares of CRSP for 59.91 per share on Apr 15 ’24. After the transaction, the Chief Executive Officer now owns 208,122 company shares. In a previous transaction on Mar 15 ’24, Kulkarni Samarth sold 20,000 shares at 72.48 per share. CRSP shares that Chief Executive Officer owns now total 208,122.

Among the insiders who sold shares, Prasad Raju disposed of 3,524 shares on Mar 15 ’24 at a per-share price of $72.69. This resulted in the Chief Financial Officer holding 6,476 shares of CRSP after the transaction. In another insider transaction, Kulkarni Samarth sold 4,583 shares at $74.44 per share on Mar 12 ’24. Company shares held by the Chief Executive Officer now total 208,122.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CRSP has a high of $91.10 and a low of $37.55.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CRSP’s latest balance sheet shows that the firm has $2.38B in Cash & Short Term Investments as of fiscal 2021. There were $225.03M in debt and $119.88M in liabilities at the time. Its Book Value Per Share was $23.52, while its Total Shareholder’s Equity was $2.40B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRSP is Buy with a score of 3.81.

Most Popular

Related Posts